文献速递认知障碍与痴呆

性别对淀粉样病理的影响:种族、祖先与APOEε4在混合尸检样本中的作用

Sex Differences in Amyloid Pathology by Race, Ancestry, and Apolipoprotein E ε4 in an Admixed Autopsy Sample.
PubMed 文献 · JAMA Neurol · 2026-01-01

该横断面研究分析巴西圣保罗大学老龄化研究生物库2004年4月至2025年3月间2268例尸检样本,探讨性别是否影响神经炎性斑块负荷和认知结局,以及性别是否修饰APOEε4、告密者报告的种族和非洲祖先比例的作用。结果显示女性斑块负荷高于男性(未调整OR 1.97,95%CI 1.67-2.29,P<.001;调整后OR 1.65,95%CI 1.33-2.20,P<.001),APOEε4携带者斑块几率约高4倍,并发现性别、APOEε4、种族和祖先对CERAD评分的显著二向交互作用。

要点

  • 女性神经炎性斑块负担高于男性,调整社会人口学、血管因素和APOEε4后仍显著。
  • APOEε4携带者无论性别,斑块几率约增加4倍。
  • 黑人非携带者和非洲祖先非携带者高斑块负担几率最低,ε4携带者中该保护减弱。

核心结论

  • 女性、APOEε4、种族和非洲祖先在本研究人群中与淀粉样病理联合相关。
  • 女性过多的淀粉样蛋白可能部分解释其更高的tau负荷和更陡的认知下降。

研究设计与样本

  • 横断面研究,使用巴西圣保罗大学老龄化研究生物库的尸检神经病理数据。
  • 纳入2004年4月至2025年3月间2268例基于人群的多样化临床病理样本尸检。

主要发现

  • 女性斑块负荷高于男性(未调整OR 1.97;95%CI 1.67-2.29;P<.001),调整后OR 1.65;95%CI 1.33-2.20;P<.001。
  • APOEε4携带者两性斑块几率约高4倍。
  • 黑人非携带者(OR 0.47;95%CI 0.34-0.67)和非洲祖先非携带者(OR 0.57;95%CI 0.43-0.76)高斑块负担几率最低。
  • CERAD评分≥2者中,女性达到Braak V-VI期的概率比男性高(概率比1.25;95%CI 1.13-1.38;P=.002)。
  • 多变量模型加入Braak分期后,女性-男性斑块差异减弱,性别与斑块对CDR-SB的交互作用不再显著。

关键数值与推荐

  • 神经炎性斑块负担采用CERAD评分评估。
  • 认知功能采用CDR-SB评估。
  • 有序logistic回归分析性别与CERAD评分的关联及性别、种族、祖先、APOEε4间的二向和三向交互作用,调整年龄、教育、血管因素和Braak分期。

临床怎么用

  • 应把性别、种族和祖先纳入阿尔茨海默病的生物标志物阈值、风险分层和预防或疾病修饰试验设计。

局限性

  • 横断面尸检研究,不能确立因果关系。
  • 其他种族组因数量少未纳入分析。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Sex and racial or ancestral disparities in Alzheimer disease remain incompletely understood; autopsy studies that examine amyloid, tau, and genetic factors are scarce. OBJECTIVE: To test whether neuritic plaque burden and cognitive outcomes differ by sex and whether sex modifies the effects of apolipoprotein E ε4 (APOEε4), informant-reported race, and African ancestry. DESIGN, SETTING, AND PARTICIPANTS: This was a cross-sectional study using postmortem neuropathological data from the Biobank for Aging Studies, University of São Paulo, São Paulo, Brazil. A total of 2268 autopsies from a population-based, diverse clinicopathological sample were collected between April 2004 and March 2025. EXPOSURES: Sex, informant-reported race (Black, White), African ancestry proportion, and APOEε4 carrier status. MAIN OUTCOMES AND MEASURES: Neuritic plaque burden (Consortium to Establish a Registry for Alzheimer's Disease [CERAD] score), and cognitive function (Clinical Dementia Rating-Sum of Boxes [CDR-SB]). Ordinal logistic regression examined association of sex with CERAD scores and 2- and 3-way interactions among sex, race, ancestry, and APOEε4; adjusting for age, education, vascular factors, and Braak stages. Linear models related pathology to CDR-SB, adding copathologies. RESULTS: The analysis included 2268 autopsies (median [IQR] age, 74.8 [63.8-83.3] years; 1152 [51% male] and 1116 [49%] female; 802 [35%] Black and 1466 [65%] White; other race groups not included owing to small numbers); female individuals were older than male individuals and more likely to exhibit cognitive impairment (CDR global score ≥0.5). Female individuals had higher plaque burden than male individuals (unadjusted odds ratio [OR], 1.97; 95% CI, 1.67-2.29; P < .001), and this association remained significant in adjusted models for sociodemographic and vascular factors and APOEε4 status (adjusted OR, 1.65; 95% CI, 1.33-2.20; P < .001). APOEε4 carriers of both sexes had an approximately 4-fold greater odds of plaques. Significant 2-way interactions were found between sex, APOEε4 status, race, and ancestry on CERAD scores. Black noncarriers (OR, 0.47; 95% CI, 0.34-0.67) and noncarriers of African ancestry (OR, 0.57; 95% CI, 0.43-0.76) were least likely to have high plaque burden, whereas this protection was weakened in ε4 carriers. No significant 3-way interaction was detected. Among individuals with a CERAD score of 2 or higher, female individuals were more likely than male individuals to reach Braak stage V-VI than male individuals (probability ratio, 1.25; 95% CI, 1.13-1.38; P = .002). Adding Braak stage to multivariable models attenuated the female-male difference in plaques and interaction of sex and plaque on CDR-SB was no longer significant. CONCLUSIONS AND RELEVANCE: The findings indicate that female sex, APOEε4, and both race and African ancestry were jointly associated with amyloid in this study population. Excess amyloid among women may partly explain their greater tau burden and steeper cognitive decline. These findings highlight the importance of incorporating sex, race, and ancestry into biomarker thresholds, risk stratification, and the design of preventive or disease-modifying trials for Alzheimer disease.

来源:JAMA Neurol,查看原文。版权归原作者所有。

引用

  1. Abu Raya M, Suemoto CK, Paes VR, et al. Sex Differences in Amyloid Pathology by Race, Ancestry, and Apolipoprotein E ε4 in an Admixed Autopsy Sample. JAMA Neurol. 2026. PMID: 41729539. doi:10.1001/jamaneurol.2026.0054

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。